Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kiniksa Pharmaceuticals International (KNSA) Other Non-Current Liabilities: 2021-2024

Historic Other Non-Current Liabilities for Kiniksa Pharmaceuticals International (KNSA) over the last 4 years, with Dec 2024 value amounting to $1.8 million.

  • Kiniksa Pharmaceuticals International's Other Non-Current Liabilities rose 640.32% to $14.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $14.5 million, marking a year-over-year increase of 640.32%. This contributed to the annual value of $1.8 million for FY2024, which is 1.88% down from last year.
  • As of FY2024, Kiniksa Pharmaceuticals International's Other Non-Current Liabilities stood at $1.8 million, which was down 1.88% from $1.9 million recorded in FY2023.
  • Kiniksa Pharmaceuticals International's 5-year Other Non-Current Liabilities high stood at $1.9 million for FY2023, and its period low was $270,000 during FY2021.
  • Over the past 3 years, Kiniksa Pharmaceuticals International's median Other Non-Current Liabilities value was $1.8 million (recorded in 2022), while the average stood at $1.8 million.
  • In the last 5 years, Kiniksa Pharmaceuticals International's Other Non-Current Liabilities skyrocketed by 581.11% in 2022 and then declined by 1.88% in 2024.
  • Over the past 4 years, Kiniksa Pharmaceuticals International's Other Non-Current Liabilities (Yearly) stood at $270,000 in 2021, then soared by 581.11% to $1.8 million in 2022, then increased by 1.03% to $1.9 million in 2023, then declined by 1.88% to $1.8 million in 2024.